Jounce Therapeutics, Inc. Contracts & Agreements

Lease Termination Agreement, by and between the Company and the Landlord, dated May 2, 2023 (Filed With SEC on May 4, 2023)

Agreement and Plan of Merger between the Company, Concentra and Merger Sub, dated March 26, 2023 (Filed With SEC on March 27, 2023)

Form of Restricted Stock Unit Award Agreement Amendment under 2017 Stock Option and Incentive Plan (for employees) (Filed With SEC on March 10, 2023)

Form of Non-Qualified Stock Option Agreement Inducement Grant for Employees, as amended (Filed With SEC on March 10, 2023)

First Amendment to Lease Agreement by and between ARE-770/784/790 Memorial Drive, LLC and the Registrant, dated March 21, 2017 (Filed With SEC on March 10, 2023)

Asset Purchase and License Amendment Agreement by and between the Company and Gilead dated December 27, 2022 (Filed With SEC on December 27, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 4, 2022)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 2, 2022)

Sales Agreement, dated as of November 4, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on November 4, 2021)

Form of Non-Qualified Stock Option Agreement Inducement Grant for Employees (Filed With SEC on August 5, 2021)

Underwriting Agreement, dated March 9, 2021, by and among Jounce Therapeutics, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters... (Filed With SEC on March 10, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)

License Agreement by and between the Registrant and Gilead Sciences, Inc., dated as of August 31, 2020 (Filed With SEC on November 6, 2020)

Stock Purchase Agreement by and between the Registrant and Gilead Sciences, Inc. dated as of August 31, 2020 (Filed With SEC on November 6, 2020)

Registration Rights Agreement by and between the Registrant and Gilead Sciences, Inc., dated as of August 31, 2020 (Filed With SEC on November 6, 2020)

Description of Securities (Filed With SEC on February 27, 2020)

Sales Agreement, dated as of December 17, 2019, by and between the Company and Cowen and Company, LLC (Filed With SEC on December 17, 2019)

License Agreement by and among the Registrant, Celgene Corporation, and Celgene RIVOT LLC, dated July 22, 2019 (Filed With SEC on November 7, 2019)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 8, 2019)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 13, 2018)

Form of Restricted Stock Unit Award Agreement under 2017 Stock Option and Incentive Plan (for employees) (Filed With SEC on August 9, 2018)

2017 Employee Stock Purchase Plan, As Amended (Filed With SEC on November 13, 2017)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 13, 2017)

LEASE TERMINATION AGREEMENT (Filed With SEC on May 23, 2017)

SUBLEASE TERMINATION AGREEMENT (Filed With SEC on May 23, 2017)

Jounce Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2017)

JOUNCE THERAPEUTICS, INC. 2017 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on January 17, 2017)

JOUNCE THERAPEUTICS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 17, 2017)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 17, 2017)

JOUNCE THERAPEUTICS, INC. FORM OF OFFICER INDEMNIFICATION AGREEMENT (Filed With SEC on January 17, 2017)

JOUNCE THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on January 17, 2017)